(Q54039771)
Statements
Comparison of three approaches to doxorubicin therapy: free doxorubicin, liposomal doxorubicin, and beta-glucuronidase-activated prodrug (HMR 1826). (English)
Woessner R
An Z
Li X
Hoffman RM
Dix R
Bitonti A
1 July 2000
20
4
2289-2296